Aging quietly prepares lungs for disease
Lung disease kills more people than most realize. And aging is the silent driving force behind nearly all of it — even when the immediate cause appears to come from outside.
A review article on Fight Aging describes how the changes that accompany aging systematically increase lung vulnerability. The authors explain how chronic low-grade inflammation, often called inflammaging, damages the lung epithelium — the cellular lining of the airways. This weakens the barrier function of that tissue, making infections easier to establish and slowing recovery after injury.
At the same time, the number of senescent cells in lung tissue increases with age. Senescent cells stop dividing but remain metabolically active and secrete substances that damage surrounding tissue. In the lungs, this contributes to diseases like COPD and pulmonary fibrosis. Those diseases are not only the result of smoking or air pollution: underlying tissue aging lowers the threshold at which those triggers cause serious harm.
Lung decline starts earlier than expected
The article emphasizes that lung function begins to decline relatively early in life. After age thirty, lung capacity gradually decreases in most people. That is normal and may cause no problems. But in those where the decline is faster, or where other aging processes weaken the tissue, the threshold for disease is lower.
This makes lung function a useful indicator of biological age more broadly. It is relatively easy to measure and responds sensitively to systemic aging processes.
Potential intervention points
The review also discusses potential targets for intervention. Reducing inflammaging in lung tissue, clearing senescent cells, and supporting the regenerative capacity of the epithelium are all directions under active investigation. None has a proven clinical application in humans yet, but the underlying mechanisms are better mapped than before. That is a prerequisite for targeted treatments.